BARRIERS TO ENTRY IN THE CANADIAN PHARMACEUTICAL-INDUSTRY - COMMENTS, CLARIFICATION AND EXTENSIONS

被引:6
作者
GORECKI, PK
机构
关键词
D O I
10.1016/0167-6296(87)90031-2
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:59 / 72
页数:14
相关论文
共 31 条
[11]   THE IMPACT OF THE PARCOST PROGRAM ON PRESCRIPTION DRUG PRICES IN ONTARIO - SOME QUERIES [J].
GORECKI, PK .
CANADIAN PUBLIC POLICY-ANALYSE DE POLITIQUES, 1982, 8 (03) :358-361
[12]  
GORECKI PK, 1987, INT J IND ORG, V4, P371
[13]  
GORECKI PK, 1980, JUN CAN EC ASS ANN M
[14]  
GORECKI PK, 1986, COMPULSORY PATENT LI
[15]  
GORECKI PK, 1981, 8 EC COUNC CAN TECHN
[16]  
GORECKI PK, 1986, FIRMS MARKETS ESSAYS, P159
[17]  
HANSEN RW, 1977, 7710 U ROCH CTR RES
[18]   THE EFFECTS OF COMPETITION ON PRESCRIPTION-DRUG PRODUCT SUBSTITUTION [J].
KRALEWSKI, JE ;
PITT, L ;
DOWD, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (04) :213-216
[19]  
Masson A., 1985, GENERIC SUBSTITUTION
[20]   SOME EMPIRICAL-EVIDENCE ON POST-PATENT BARRIERS TO ENTRY IN THE CANADIAN PHARMACEUTICAL-INDUSTRY [J].
MCRAE, JJ ;
TAPON, F .
JOURNAL OF HEALTH ECONOMICS, 1985, 4 (01) :43-61